Follow Andrew on: Tetra Bio-Pharma ships inhaled cannabis drug QIKLEEF to US ahead of opioid comparision study in patients with breakthrough cancer pain REBORN1 will evaluate cannabis as an alternative to morphine sulfate immediate release, an opioid, in the management of breakthrough pain Tetra Bio-Pharma has completed the manufacturing of QIXLEEF and received the necessary cannabis export permit from Health Canada Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1) said it has shipped its investigational new drug, QIXLEEF, to the US to initiate the planned REBORN1 study of p...